MedPath

NMT Medical

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (100.0%)

MIST II PFO-Migraine Trial With BioSTAR® Bioabsorbable Septal Repair Implant

Phase 2
Conditions
Migraine
Aura
Patent Foramen Ovale
First Posted Date
2006-01-30
Last Posted Date
2008-01-25
Lead Sponsor
NMT Medical
Target Recruit Count
610
Registration Number
NCT00283738
Locations
🇺🇸

New England Center for Headache, Stamford, Connecticut, United States

🇺🇸

Swedish Medical Center, Seattle, Washington, United States

Evaluation of the STARFlex® Septal Closure System in Patients With a Stroke or TIA Due to the Possible Passage of a Clot of Unknown Origin Through a Patent Foramen Ovale (PFO)

Phase 2
Conditions
Patent Foramen Ovale
Stroke
Ischemic Attack, Transient
Interventions
Drug: Best medical therapy
Device: STARFlex septal closure system
First Posted Date
2005-09-20
Last Posted Date
2008-12-30
Lead Sponsor
NMT Medical
Target Recruit Count
900
Registration Number
NCT00201461
Locations
🇺🇸

The Cleveland Clinic Foundation, Cleveland, Ohio, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.